Development of Radiogallium-Labeled Peptides for Platelet-Derived Growth Factor Receptor
Animals
Apoptosis
Cell Proliferation
Female
Gallium Radioisotopes
/ chemistry
Humans
Male
Mice
Mice, Inbred BALB C
Mice, Nude
Peptide Fragments
/ chemistry
Prostatic Neoplasms
/ metabolism
Radiopharmaceuticals
/ chemistry
Receptor, Platelet-Derived Growth Factor beta
/ metabolism
Tissue Distribution
Tumor Cells, Cultured
Xenograft Model Antitumor Assays
PDGFRβ
imaging
peptide
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
23 Dec 2020
23 Dec 2020
Historique:
received:
30
11
2020
revised:
17
12
2020
accepted:
21
12
2020
entrez:
30
12
2020
pubmed:
31
12
2020
medline:
10
4
2021
Statut:
epublish
Résumé
The purpose of this study is to develop peptide-based platelet-derived growth factor receptor
Identifiants
pubmed: 33374773
pii: molecules26010041
doi: 10.3390/molecules26010041
pmc: PMC7795354
pii:
doi:
Substances chimiques
Gallium Radioisotopes
0
Peptide Fragments
0
Radiopharmaceuticals
0
Gallium-67
4LJK511Z86
PDGFRB protein, human
EC 2.7.10.1
Receptor, Platelet-Derived Growth Factor beta
EC 2.7.10.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Nucl Med Biol. 2015 Nov;42(11):816-23
pubmed: 26302836
Adv Cancer Res. 2007;97:247-74
pubmed: 17419949
PLoS One. 2013 Dec 31;8(12):e84335
pubmed: 24391942
Mol Imaging Biol. 2013 Apr;15(2):212-21
pubmed: 22791264
J Am Chem Soc. 2002 Dec 18;124(50):14922-33
pubmed: 12475334
Mol Pharm. 2014 Nov 3;11(11):3957-64
pubmed: 24972112
Cytokine Growth Factor Rev. 2004 Aug;15(4):275-86
pubmed: 15207817
J Control Release. 2019 Mar 28;298:194-201
pubmed: 30763622
J Biol Chem. 2003 Dec 5;278(49):49582-8
pubmed: 14506245
Mol Cell Biol. 2000 Nov;20(22):8352-63
pubmed: 11046132
Bioconjug Chem. 2008 Feb;19(2):539-47
pubmed: 18197608
Bioorg Med Chem. 2017 Oct 15;25(20):5576-5585
pubmed: 28838832
Bioconjug Chem. 2008 Sep;19(9):1803-12
pubmed: 18712899
Nucl Med Biol. 2013 Feb;40(2):197-205
pubmed: 23218795
Bioconjug Chem. 2009 Dec;20(12):2199-213
pubmed: 19719118
Nucl Med Biol. 2006 May;33(4):513-20
pubmed: 16720243
Theranostics. 2012;2(5):481-501
pubmed: 22737187
Protein Cell. 2019 Nov;10(11):787-807
pubmed: 31140150
J Nucl Med. 2014 Feb;55(2):294-300
pubmed: 24408895
Mol Pharm. 2014 Nov 3;11(11):3938-46
pubmed: 25054774
PLoS One. 2013 Aug 01;8(8):e70028
pubmed: 23936372
Curr Top Med Chem. 2010;10(12):1227-36
pubmed: 20388106
Sci Rep. 2017 Oct 25;7(1):13971
pubmed: 29070853
Sci Rep. 2018 Jul 10;8(1):10369
pubmed: 29991770
J Biol Chem. 1993 Feb 15;268(5):3625-31
pubmed: 7679113
Chem Pharm Bull (Tokyo). 2018;66(6):651-659
pubmed: 29863067
Nucl Med Biol. 2010 Oct;37(7):751-61
pubmed: 20870150
Nucl Med Biol. 2013 May;40(4):445-50
pubmed: 23528561
Chem Pharm Bull (Tokyo). 2020;68(6):538-545
pubmed: 32475858
Theranostics. 2011 Jan 18;1:58-82
pubmed: 21547153
Adv Drug Deliv Rev. 2017 Feb;110-111:38-51
pubmed: 27327937
Breast Cancer Res Treat. 2018 Jun;169(2):231-241
pubmed: 29380207
Mol Ther. 2014 Apr;22(4):828-41
pubmed: 24566984
ACS Med Chem Lett. 2013 Jan 1;4(1):98-102
pubmed: 23524643
Bioorg Med Chem. 2019 Jan 15;27(2):383-393
pubmed: 30563725
Oncol Rep. 2018 May;39(5):2178-2184
pubmed: 29498405
Bioconjug Chem. 2009 May 20;20(5):856-67
pubmed: 19344122
Ann Nucl Med. 2019 Apr;33(4):244-251
pubmed: 30604401
Mol Pharm. 2009 Jan-Feb;6(1):231-45
pubmed: 19067525
Science. 1995 Mar 24;267(5205):1782-8
pubmed: 7892601
World J Surg. 2016 Aug;40(8):1977-84
pubmed: 26940582
Nucl Med Biol. 2011 Jul;38(5):631-6
pubmed: 21718937
Molecules. 2017 Aug 02;22(8):
pubmed: 28767081
Mol Imaging Biol. 2013 Aug;15(4):391-400
pubmed: 23381728
J Nucl Med. 2011 Mar;52(3):470-7
pubmed: 21321264
J Nucl Med. 2003 May;44(5):823-31
pubmed: 12732685
Bioconjug Chem. 2015 Aug 19;26(8):1561-70
pubmed: 26087328
Mol Pharm. 2017 Feb 6;14(2):523-532
pubmed: 28094532